DNA and Gene Cloning Services Market Revenue to Cross USD 14.5 Billion by 2035 | Roots Analysis

Published: February 2024


According to a recently published report by Roots Analysis, the growing preferences for molecular techniques for the synthesis of drugs and gene therapies are anticipated to drive the DNA and gene cloning services market during the forecast period.

DNA and Gene Cloning Services Market Overview

The global DNA and gene cloning services market is anticipated to grow at a CAGR of 15.93% from 2023-2035, reaching USD 14.5 billion by 2035.

Cloning refers to a process of creating identical copies of DNA and genes that are used in various research and therapeutic applications. Advancements in cloning and genetic engineering techniques enable researchers to modify the genome of microorganisms and use them to produce gene therapies. These target-specific therapies have shown significant potential in the treatment of serious disease indications such as AIDS, cystic fibrosis, and others. It is worth noting here that DNA and gene cloning often play a significant role in the production of antibiotics, hormones, and vitamins. Owing to the several applications of DNA and gene cloning, several researchers have taken the initiative to construct gene libraries that comprise cloned DNA. However, the DNA and gene cloning processes may pose complications such as gene toxicity, unstable DNA elements, and the requirement of particular gene insert sizes and vectors. To address the concerns, several industrial stakeholders have begun to outsource DNA and gene cloning to obtain high-quality and stable final products. Currently, there are several service providers available in the field with the required expertise and technological support to meet the demand for DNA clones. It is worth highlighting here that several researches have been conducted on DNA cloning technologies—this is evident from over 6,900 research articles that have been published on various research websites for DNA cloning technologies in the past few decades. The ongoing demand for gene therapies and the growing adoption of advanced DNA cloning technologies are anticipated to grow the market at a steady rate during the forecast period.

The 228 pages report contain detailed Table of Content on “by DNA and gene cloning services market Type of Services Offered, Type of Gene, Company Size, End User and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035” here: https://www.rootsanalysis.com/reports/dna-and-gene-cloning-market.html

Market Drivers

The increasing demand for tailored DNA constructs to develop various therapeutic applications, such as gene therapies and functional genomics, is driving the DNA and gene cloning services market. Additionally, the rising focus on research and development activities for the development of target-specific therapeutic drugs such as recombinant proteins, biopharmaceutical products, and monoclonal antibodies has surged the requirement for DNA clones, which is anticipated to drive the market. The growing emphasis on regulatory compliance to ensure the safety and efficacy of drugs developed from DNA clones has further accelerated the DNA and gene cloning services market.

Market Restraints

The complexity of gene editing technologies and off-target effects are the major challenges of the DNA and gene cloning services market. Further, the lack of standardization in DNA cloning protocols and methodologies may create significant challenges for the service providers. The DNA and gene cloning process creates an enormous amount of genomic data that has to be stored adequately to avoid unauthorized access to sensitive information. Data privacy and security concerns may also impede the growth of the DNA and gene cloning market during the forecast period.

Growth Factors

Several growth factors that are propelling the DNA and gene cloning services market include a rise in funding and investments by industrial and non-industrial players for genomic research initiatives. Continuous innovation in cloning technologies and high-throughput methodologies to improve the efficacy and accuracy of DNA cloning has caught the attention of industrial leaders. The global initiatives and increasing focus on genetic engineering and research programs have further fueled the DNA and gene cloning services market.

DNA and Gene Cloning Market Market Segment

Based on the type of services offered, the DNA and gene cloning market is segmented into gene synthesis, custom cloning, sub-cloning, and others.

  • Based on the type of services offered, the DNA and gene cloning market is dominated by custom cloning, capturing 47% of the overall revenue share by 2035.
  • Custom cloning will grow at a higher CAGR of 17.31% during the forecast period.

Based on the type of gene, the DNA and gene cloning market is segmented into standard genes, complex genes, and others.

  • The complex gene will dominate the DNA and gene cloning market and is anticipated to capture 55% of the overall revenue share by 2035.
  • The complex gene will grow at a higher compounded annual growth rate (CAGR) of 16.74% during the forecast period.

Based on the company size, the DNA and gene cloning market is segmented into small, mid-sized, and large companies.

  • Large companies will dominate the DNA and gene cloning market and are anticipated to capture 60% of the overall market share.
  • In the long run, large companies have shown significant growth potential and are poised to grow at a CAGR of 19.69% during the forecast period.

Based on the type of end-user, the DNA and gene cloning services market is segmented into academic and R&D, pharmaceutical and biotechnology companies, and others.

  • Based on the type of end-user, pharmaceutical and biotechnology companies will dominate the market, capturing 57% of the overall market share by 2035.
  • Academic and R&D will grow during the forecast period at a higher compounded annual growth rate (CAGR) of 16.36%.

Based on the Regional Insights, the DNA and Gene Cloning Services Market is segmented into North America, Europe, Asia-Pacific, Latin America, and MENA.

  • North America is anticipated to hold the maximum share (38%) of the global DNA and gene cloning market by 2035.
  • In MENA, the DNA and gene cloning services market is anticipated to demonstrate lucrative growth and is poised to grow at a CAGR of 20.76% during the forecast period.

Key Companies Profiled

The DNA and gene cloning services market report also includes detailed profiles of key players (listed below) that offer aseptic sampling solutions:

  • Aragen Life Sciences
  • Bio-Techne
  • Charles River Laboratories
  • Curia
  • Eurofins
  • GenScript
  • Integrated DNA Technologies
  • MedGenome
  • Sino Biological
  • Syngene
  • Twist Bioscience

You Can Download Free Sample PDF Copy Of This Report At:
https://www.rootsanalysis.com/reports/dna-and-gene-cloning-market/request-sample.html

Don’t miss out on other interesting titles:

  1. Allogeneic Cell Therapy Market
  2. Plasmid DNA Manufacturing Market
  3. Antibody Discovery Market
  4. Gene Therapy, Non-Viral Vector and Viral Vector Manufacturing Market

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists, and strategic investors for over a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.

Contact US
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

MEDIA CITATIONS

  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry